Developing a pathway to support the appropriate, affordable, and widespread use of effective Alzheimer's prevention drugs-Reference-Cited by-同舟云学术

Developing a pathway to support the appropriate, affordable, and widespread use of effective Alzheimer's prevention drugs

Published:2022-01 Issue:1 Volume:18 Page:7-9
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Reiman Eric M.¹,Mattke Soeren²,Kordower Jeffrey H.³,Khachaturian Zaven S.⁴,Khachaturian Ara S.⁵

Affiliation:

1. Banner Alzheimer's Institute Phoenix Arizona USA

2. University of Southern California Los Angeles California USA

3. ASU‐Banner Neurodegenerative Disease Research Center (NDRC) The Charlene and J. Orin Edson Distinguished Director at the Biodesign Institute Arizona State University Phoenix Arizona USA

4. Campaign to Prevent Alzheimer's Disease Alzheimer's & Dementia: The Journal of the Alzheimer's Association Rockville Maryland USA

5. Alzheimer's & Dementia: The Journal of the Alzheimer's Association Alzheimer's & Dementia: Translational Research & Clinical Interventions Alzheimer's & Dementia: Diagnosis, Assessment and Disease Monitoring Rockville Maryland USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12533

Reference13 articles.

1. 2021 Alzheimer's disease facts and figures

2. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia

3. Subjective cognitive decline and risk of MCI

4. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer’s Disease;Journal of Alzheimer's Disease;2023-03-07

2. Improving community health‐care systems’ early detection of cognitive decline and dementia;Alzheimer's & Dementia;2022-10-31

3. Are we ready to use anti-amyloid therapy in Alzheimer's disease?;Arquivos de Neuro-Psiquiatria;2022-05